Activated leukocyte cell adhesion molecule (CD166) - Its prognostic power for colorectal cancer patients

Journal of Surgical Research

Volumn 177, Issue 1, 2012, Pages

  Tachezy, Michael ^a   Zander, Hilke ^a   Gebauer, Florian ^a   Marx, Andreas ^a   Kaifi, Jussuf T ^b   Izbicki, Jakob R ^a   Bockhorn, Maximilian ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

ALCAM; Biomarker; Cancer stem cell; CD166; Colorectal cancer; CRC; CSC; Prognosis

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; CELL ADHESION MOLECULES, NEURONAL; COLON; COLORECTAL NEOPLASMS; FEMALE; FETAL PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; LYMPH NODES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84865066555     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.02.013     Document Type: Article

References (33)

1. M.W. Russo, J.T. Wei, and M.T. Thiny Digestive and liver diseases statistics, 2004 Gastroenterology 126 2004 1448
2. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2007 CA Cancer J Clin 57 2007 43
3. D. Holzel, R. Eckel, and J. Engel [Colorectal cancer metastasis. Frequency, prognosis, and consequences] Chirurgia 80 2009 331 German
4. F.E. Johnson, K.S. Virgo, and R. Fossati Follow-up for patients with colorectal cancer after curative-intent primary treatment J Clin Oncol 22 2004 1363
5. B.M. Boman, and E. Huang Human colon cancer stem cells: A new paradigm in gastrointestinal oncology J Clin Oncol 26 2008 2828
6. P. Dalerba, S.J. Dylla, and I.K. Park Phenotypic characterization of human colorectal cancer stem cells Proc Natl Acad Sci U S A 104 2007 10158
7. R. Pardal, M.F. Clarke, and S.J. Morrison Applying the principles of stem-cell biology to cancer Nat Rev Cancer 3 2003 895
8. T. Reya, S.J. Morrison, and M.F. Clarke Stem cells, cancer, and cancer stem cells Nature 414 2001 105
9. L. Ricci-Vitiani, D.G. Lombardi, and E. Pilozzi Identification and expansion of human colon-cancer-initiating cells Nature 445 2007 111
10. D. Horst, L. Kriegl, and J. Engel Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer Cancer Invest 27 2009 844
11. C.A. O'Brien, A. Pollett, and S. Gallinger A human colon cancer cell capable of initiating tumour growth in immunodeficient mice Nature 445 2007 106
12. U.H. Weidle, D. Eggle, and S. Klostermann ALCAM/CD166: Cancer-related issues Cancer Genomics Proteomics 7 2010 231
13. J.W. van Kilsdonk, R.H. Wilting, and M. Bergers Attenuation of melanoma invasion by a secreted variant of activated leukocyte cell adhesion molecule Cancer Res 68 2008 3671
14. S.F. Ofori-Acquah, and J.A. King Activated leukocyte cell adhesion molecule: A new paradox in cancer Transl Res 151 2008 122
15. M. Ihnen, V. Muller, and R.M. Wirtz Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer Breast Cancer Res Treat 112 2008 419
16. D. Mezzanzanica, M. Fabbi, and M. Bagnoli Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients Clin Cancer Res 14 2008 1726
17. M. Tachezy, K. Effenberger, and H. Zander ALCAM (CD166) expression and serum levels are markers for poor survival of esophageal cancer patients Int J Cancer 2011 [Epub ahead of print]
18. M. Tachezy, H. Zander, and A.H. Marx ALCAM (CD166) expression as novel prognostic biomarker for pancreatic neuroendocrine tumor patients J Surg Res 170 2011 226
19. S. Minner, F. Kraetzig, and M. Tachezy Low activated leukocyte cell adhesion molecule expression is associated with advanced tumor stage and early prostate-specific antigen relapse in prostate cancer Hum Pathol 42 2011 1946
20. B. Liu, F. Conrad, and A. Roth Recombinant full-length human IgG1s targeting hormone-refractory prostate cancer J Mol Med 85 2007 1113
21. A. Roth, D.C. Drummond, and F. Conrad Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells Mol Cancer Ther 6 2007 2737
22. M.T. Wiiger, H.B. Gehrken, and O. Fodstad A novel human recombinant single-chain antibody targeting CD166/ALCAM inhibits cancer cell invasion in vitro and in vivo tumour growth Cancer Immunol Immunother 59 2010 1665
23. T.G. Levin, A.E. Powell, and P.S. Davies Characterization of the intestinal cancer stem cell marker CD166 in the human and mouse gastrointestinal tract Gastroenterology 139 2010 2072 e2075
24. W. Weichert, T. Knosel, and J. Bellach ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival J Clin Pathol 57 2004 1160
25. A. Lugli, G. Iezzi, and I. Hostettler Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer Br J Cancer 103 2010 382
26. J.T. Kaifi, U. Reichelt, and A. Quaas L1 is associated with micrometastatic spread and poor outcome in colorectal cancer Mod Pathol 20 2007 1183
27. T. Schlomm, L. Iwers, and P. Kirstein Clinical significance of p53 alterations in surgically treated prostate cancers Mod Pathol 21 2008 1371
28. G. Kristiansen, C. Pilarsky, and C. Wissmann ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions Prostate 54 2003 34
29. J.S. Ross, J. Torres-Mora, and N. Wagle Biomarker-based prediction of response to therapy for colorectal cancer: Current perspective Am J Clin Pathol 134 2010 478
30. A. Walther, E. Johnstone, and C. Swanton Genetic prognostic and predictive markers in colorectal cancer Nat Rev Cancer 9 2009 489
31. S. Tejpar, M. Bertagnolli, and F. Bosman Prognostic and predictive biomarkers in resected colon cancer: Current status and future perspectives for integrating genomics into biomarker discovery Oncologist 15 2010 390
32. C.S. Ang, J. Phung, and E.C. Nice The discovery and validation of colorectal cancer biomarkers Biomed Chromatogr 25 2011 82
33. Q. Shi, S.J. Mandrekar, and D.J. Sargent Predictive biomarkers in colorectal cancer: Usage, validation, and design in clinical trials Scand J Gastroenterol 47 2011 356